Journal article
Bispecific Antibodies in Gastric Cancer Therapeutics: New Hope for High Efficacy and Tolerability
Discovery medicine, Vol.37(198), pp.1416-1421
2025
DOI: 10.24976/Discov.Med.202537198.123
Abstract
Bispecific antibodies represent a new weapon in the solid tumor oncology armamentarium. In gastric cancer, where available targeted therapies are restricted to a minority of patients, bispecific antibodies may provide much needed new targeted options. This commentary discusses the main constructs and targets of bispecific antibodies in development for gastric cancer.
Details
- Title: Subtitle
- Bispecific Antibodies in Gastric Cancer Therapeutics: New Hope for High Efficacy and Tolerability
- Creators
- Ioannis A. Voutsadakis
- Resource Type
- Journal article
- Publication Details
- Discovery medicine, Vol.37(198), pp.1416-1421
- DOI
- 10.24976/Discov.Med.202537198.123
- ISSN
- 1539-6509
- Language
- English
- Date published
- 2025
- Academic Unit
- Internal Medicine
- Record Identifier
- 9984904215902771
Metrics
11 Record Views